MUTYH-Associated Polyposis and Colorectal Cancer

Surgical Oncology Clinics of North America

Volumn 18, Issue 4, 2009, Pages 599-610

  Dunlop, Malcolm G ^a   Farrington, Susan M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Base excision repair; Colorectal cancer; Genetic; MUTYH; Polyposis; Susceptibility

Indexed keywords

APC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; DNA GLYCOSYLASE MUTY; PROTEIN KINASE LKB1; PROTEIN MSH6; PROTEIN MUTS; SMAD4 PROTEIN;

AUTOSOMAL RECESSIVE INHERITANCE; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL FEATURE; COLON CARCINOGENESIS; COLON POLYPOSIS; COLORECTAL CANCER; COLORECTAL SURGERY; EXCISION REPAIR; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY; HETEROZYGOTE; HUMAN; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MISSENSE MUTATION; NUCLEIC ACID BASE SUBSTITUTION; ONSET AGE; OXIDATIVE STRESS; REVIEW;

ADENOMATOUS POLYPOSIS COLI; COLORECTAL NEOPLASMS; DNA GLYCOSYLASES; DNA REPAIR; HUMANS;

EID: 70349452209     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2009.08.003     Document Type: Review

References (42)

1. Dunlop M.G., Farrington S.M., Nicholl I., et al. Population carrier frequency of hMSH2 and hMLH1 mutations. Br J Cancer 83 12 (2000) 1643-1645
2. Aaltonen L., Johns L., Jarvinen H., et al. Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors. Clin Cancer Res 13 1 (2007) 356-361
3. Jenkins M.A., Baglietto L., Dite G.S., et al. After hMSH2 and hMLH1-what next? Analysis of three-generational, population-based, early-onset colorectal cancer families. Int J Cancer 102 2 (2002) 166-171
4. Lubbe S.J., Di Bernardo M.C., Chandler I.P., et al. Clinical implications of the colorectal cancer risk associated with MUTYH mutation. J Clin Oncol 27 24 (2009) 3975-3980
5. Tenesa A., and Dunlop M.G. New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat Rev Genet (May 12, 2009) [Epub ahead of print]
6. Nielsen M., Joerink-van de Beld M.C., Jones N., et al. Analysis of MUTYH genotypes and colorectal phenotypes in patients with MUTYH-associated polyposis. Gastroenterology 136 2 (2009) 471-476
7. Cleary S.P., Cotterchio M., Jenkins M.A., et al. Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology 136 4 (2009) 1251-1260
8. Tenesa A., Campbell H., Barnetson R., et al. Association of MUTYH and colorectal cancer. Br J Cancer 95 2 (2006) 239-242
9. Al-Tassan N., Chmiel N.H., Maynard J., et al. Inherited variants of MYH associated with somatic G:C->T:A mutations in colorectal tumors. Nat Genet 30 2 (2002) 227-232
10. Jones S., Emmerson P., Maynard J., et al. Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C->T:A mutations. Hum Mol Genet 11 23 (2002) 2961-2967
11. Sampson J.R., Dolwani S., Jones S., et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 362 9377 (2003) 39-41
12. Poulsen M.L., and Bisgaard M.L. MUTYH Associated Polyposis (MAP). Curr Genomics 9 6 (2008) 420-435
13. Sieber O.M., Lipton L., Crabtree M., et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 348 9 (2003) 791-799
14. Venesio T., Molatore S., Cattaneo F., et al. High frequency of MYH gene mutations in a subset of patients with familial adenomatous polyposis. Gastroenterology 126 7 (2004) 1681-1685
15. Croitoru M.E., Cleary S.P., Di Nicola N., et al. Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst 96 21 (2004) 1631-1634
16. Enholm S., Hienonen T., Suomalainen A., et al. Proportion and phenotype of MYH-associated colorectal neoplasia in a population-based series of Finnish colorectal cancer patients. Am J Pathol 163 3 (2003) 827-832
17. Farrington S.M., Tenesa A., Barnetson R., et al. Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am J Hum Genet 77 1 (2005) 112-119
18. Wang L., Baudhuin L.M., Boardman L.A., et al. MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology 127 1 (2004) 9-16
19. Dallosso A.R., Dolwani S., Jones N., et al. Inherited predisposition to colorectal adenomas caused by multiple rare alleles of MUTYH but not OGG1, NUDT1, NTH1 or NEIL 1, 2 or 3. Gut 57 9 (2008) 1252-1255
20. David S.S., O'Shea V.L., and Kundu S. Base-excision repair of oxidative DNA damage. Nature 447 7147 (2007) 941-950
21. Mazurek A., Berardini M., and Fishel R. Activation of human MutS homologs by 8-oxo-guanine DNA damage. J Biol Chem 277 10 (2002) 8260-8266
22. Gu Y., Parker A., Wilson T.M., et al. Human MutY homolog, a DNA glycosylase involved in base excision repair, physically and functionally interacts with mismatch repair proteins human MutS homolog 2/human MutS homolog 6. J Biol Chem 277 13 (2002) 11135-11142
23. Colussi C., Parlanti E., Degan P., et al. The mammalian mismatch repair pathway removes DNA 8-oxodGMP incorporated from the oxidized dNTP pool. Curr Biol 12 11 (2002) 912-918
24. Cheadle J.P., and Sampson J.R. MUTYH-associated polyposis-from defect in base excision repair to clinical genetic testing. DNA Repair (Amst) 6 3 (2007) 274-279
25. Kambara T., Whitehall V.L., Spring K.J., et al. Role of inherited defects of MYH in the development of sporadic colorectal cancer. Genes Chromosomes Cancer 40 1 (2004) 1-9
26. Lipton L., Halford S.E., Johnson V., et al. Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway. Cancer Res 63 22 (2003) 7595-7599
27. Jenkins M.A., Croitoru M.E., Monga N., et al. Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study. Cancer Epidemiol Biomarkers Prev 15 2 (2006) 312-314
28. Jones N., Vogt S., Nielsen M., et al. Increased colorectal cancer incidence in obligate carriers of heterozygous mutations in MUTYH. Gastroenterology 137 2 (2009) 489-494 494.e1; quiz 725-486
29. Sieber O.M., Howarth K.M., Thirlwell C., et al. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice. Cancer Res 64 24 (2004) 8876-8881
30. O'Shea A.M., Cleary S.P., Croitoru M.A., et al. Pathological features of colorectal carcinomas in MYH-associated polyposis. Histopathology 53 2 (2008) 184-194
31. Gismondi V., Meta M., Bonelli L., et al. Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas. Int J Cancer 109 5 (2004) 680-684
32. Parker A.R., Sieber O.M., Shi C., et al. Cells with pathogenic biallelic mutations in the human MUTYH gene are defective in DNA damage binding and repair. Carcinogenesis 26 11 (2005) 2010-2018
33. Vasen H.F., Moslein G., Alonso A., et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 57 5 (2008) 704-713
34. Aretz S., Uhlhaas S., Goergens H., et al. MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer 119 4 (2006) 807-814
35. Nielsen M., Poley J.W., Verhoef S., et al. Duodenal carcinoma in MUTYH-associated polyposis. J Clin Pathol 59 11 (2006) 1212-1215
36. de Ferro S.M., Suspiro A., Fidalgo P., et al. Aggressive phenotype of MYH-associated polyposis with jejunal cancer and intra-abdominal desmoid tumor: report of a case. Dis Colon Rectum 52 4 (2009) 742-745
37. Dolwani S., Williams G.T., West K.P., et al. Analysis of inherited MYH/(MutYH) mutations in British Asian patients with colorectal cancer. Gut 56 4 (2007) 593
38. Leite J.S., Isidro G., Martins M., et al. Is prophylactic colectomy indicated in patients with MYH-associated polyposis?. Colorectal Dis 7 4 (2005) 327-331
39. Dube C., Rostom A., Lewin G., et al. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 146 5 (2007) 365-375
40. Chan A.T., Ogino S., and Fuchs C.S. Aspirin use and survival after diagnosis of colorectal cancer. JAMA 302 6 (2009) 649-658
41. Burn J., Bishop D.T., Mecklin J.P., et al. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl J Med 359 24 (2008) 2567-2578
42. Burn J. Presented at 3rd Biennial Scientific Meeting; InSiGHT conference. Dusseldorf, June, 2009. Family Cancer, in press.